Argan INC Form 4 insider transactions

Director William F. Leimkuhler of Argan Inc. (AGX) sold 10,000 shares of common stock on September 23, 2024, at an average price of $96.20 per share.

William F. Griffin Jr., a director at Argan Inc., sold 20,000 shares of the company's common stock on September 17, 2024.

Richard H. Deily, CFO and SVP of Argan Inc., reports the vesting and subsequent issuance of 4,167 shares of common stock from Time-Based Restricted Stock Units (TRSUs) on September 13, 2024.

Director James W. Quinn reported selling 20,000 shares of Argan Inc. (AGX) common stock in open market transactions on September 10 and 11, 2024.

Argan Inc.'s CEO, David Hibbert Watson, exercised stock options on September 10, 2024, increasing his direct holdings in the company.

Director Rainer H. Bosselmann of Argan Inc. (AGX) recently sold a total of 27,840 shares of the company's common stock in open market transactions.

Mano S. Koilpillai, a former director of Argan Inc., sold 2,633 shares of the company's common stock at an average price of $76.92 per share on July 30, 2024.

William F. Griffin Jr., a director at Argan Inc., executed multiple sales of the company's common stock on the open market between July 29 and July 31, 2024.

Director Peter W. Getsinger sold 1,405 shares of Argan Inc. (AGX) on July 24, 2024, at an average price of $78.36 per share.

Argan Inc.'s CEO, David Hibbert Watson, sold 15,134 shares of the company's common stock on July 24, 2024, at an average price of $77.79 per share.

Director Peter W. Getsinger exercised stock options to acquire 2,405 shares of Argan Inc. (AGX) common stock on July 19, 2024.

Rainer H. Bosselmann, a director at Argan Inc. (AGX), sold 17,000 shares of common stock at an average price of $69.23 on July 10, 2024.

Director Rainer H. Bosselmann exercised stock options and sold shares of Argan Inc. common stock.

William F. Leimkuhler, a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $31.82 per share on June 14, 2024, resulting in changes to his beneficial ownership.

Cynthia Flanders, a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $31.82 per share on June 17, 2024.

James W. Quinn, a director at Argan Inc., exercised stock options to purchase 10,000 shares at $31.82 per share, increasing his total holdings.

Richard H. Deily, CFO and SVP of Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $64.25 per share on June 14, 2024.

Argan Inc.'s CEO, David Watson, exercised stock options on June 13, 2024, resulting in changes to his beneficial ownership of the company's common stock.

Director Rainer H. Bosselmann sold a total of 50,000 shares of Argan Inc. (AGX) common stock between June 13 and June 17, 2024.

Director John R. Jeffrey Jr. exercised stock options to purchase 10,000 shares of Argan Inc. common stock at $60.05 per share on June 12, 2024, using a net settle approach.

John R. Jeffrey Jr., a director at Argan Inc., exercised options to purchase 10,000 shares of common stock at $46.35 per share on April 25, 2024.

Director Rainer H. Bosselmann of Argan Inc. (AGX) donated 8,500 shares of common stock to Riverworks Art Center, Inc. on April 24, 2024.

Director Mano S. Koilpillai sold 2,700 shares of Argan Inc. (AGX) on April 23, 2024, at a price of $61.79 per share.

Director Mitchell W G Champion sold 2,507 shares of Argan Inc. on April 19, 2024, at a price of $61.48 per share.

Director William F. Griffin Jr. reports the sale of 15,000 shares of Argan Inc. and vesting of 4,167 restricted stock units.

Director Mano S. Koilpillai exercised multiple stock options on April 17, 2024, resulting in the acquisition of common stock.

Director Mitchell W.G. Champion reports exercising stock options and selling shares of Argan Inc. common stock.

Richard H. Deily, CFO and SVP of Argan Inc., sold 6,256 shares of the company's common stock on April 19, 2024.

Charles Collins IV, CEO of Argan Inc., reports the vesting of restricted stock units and the grant of new stock options and performance-based restricted stock units.

Richard Deily, CFO and SVP of Argan Inc., reports exercising stock options and the vesting of restricted stock units, resulting in changes to his beneficial ownership of company stock.